Equity (Tables)

3 Months Ended

Mar. 31, 2021

Equity

Schedule of status of the restricted stock grants issued under the Equity Plan

		Weighted
		Average Grant
		Date Fair
	Number of	Value Per
Restricted Stock Grants	Shares	Share
Outstanding at December 31, 2020	224,002	$	0.36
Granted during the period	—		—
Restrictions lifted during the period	—		—
Forfeited during the period	—		—
Outstanding March 31, 2021	224,002	$	0.36

Schedule of restricted stock units

		Weighted
		Average Grant
		Date Fair
	Number of	Value Per
Restricted Stock Units	Shares	Share
Outstanding at December 31, 2020	3,610,038	$	0.70
Granted during the period	—		—
Restrictions lifted during the period	—		—
Forfeited during the period	—		—
Outstanding March 31, 2021	3,610,038	$	0.70

Summary of the status of the Company's common stock warrants

		Weighted
	Number of	Average Exercise
	Underlying	Price Per
Common Stock Warrants	Shares	Share
Outstanding at December 31, 2019	14,653,846	$	0.39
Granted during the period:
April 2020 Series A warrants	7,500,000		0.30
April 2020 Series B warrants	3,750,000		0.30
Exercised during period
April 2020 Series A warrants	(5,000,000)		0.30
April 2020 Series B warrants	(3,500,000)		0.30
Outstanding at December 31, 2020	17,403,846		0.38
Exercised during period
July 2019 Series A warrants	(200,000)		0.35
July 2019 Series B warrants	(1,500,000)		0.35
April 2020 Series A warrants	(1,400,000)		0.30
Outstanding March 31, 2021	14,303,846	$	0.39